Low serum calprotectin levels correlate with the presence of biological drugs after the first year of treatment in patients with rheumatoid arthritis.
Ana Martínez FeitoChamaida Plasencia-RodríguezVictoria Navarro-CompánAndrea JochemsBorja Hernández-BreijoDiana PeiteadoCarolina TorneroDora Pascual-SalcedoAlejandro BalsaPublished in: Scandinavian journal of clinical and laboratory investigation (2019)